The global generic injectables market size was valued at USD 83.09 billion in 2021 and is poised to grow at a significant CAGR of 12.2% during the forecast period 2022-28. Identical to its branded predecessor in strength, dosage form, security, performance, quality, planned use, adverse effects, and method of administration, a generic injectable is a medication that is manufactured with the same active pharmaceutical component. It is utilized to quickly administer the medication into the body and is equally safe and effective as an innovative drug. It makes liquid medications easier to absorb, reducing the amount of dosage administration without compromising the effectiveness of the medicine.